AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹120 Cr | ₹102 Cr | ₹103 Cr | ₹105 Cr | ₹129 Cr |
What is the latest Total Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹102 Cr |
| Mar2023 | ₹103 Cr |
| Mar2022 | ₹105 Cr |
| Mar2021 | ₹129 Cr |
How is Total Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | 17.68 | |
| Mar2024 | ₹102 Cr | -0.54 | |
| Mar2023 | ₹103 Cr | -2.46 | |
| Mar2022 | ₹105 Cr | -17.95 | |
| Mar2021 | ₹129 Cr | - | |
Compare Total Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹214.5 Cr | 4.5% | 6.5% | -51.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 4.5% |
6.5% |
-51.3% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses